These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 12830468)

  • 21. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hyperferritinemia.
    Shahrbanoo K; Taziki O
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):933-6. PubMed ID: 18974579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.
    Tarng DC; Huang TP; Chen TW; Yang WC
    Kidney Int Suppl; 1999 Mar; 69():S107-18. PubMed ID: 10084294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin and iron: the role of ascorbic acid.
    Tarng DC; Huang TP; Wei YH
    Nephrol Dial Transplant; 2001; 16 Suppl 5():35-9. PubMed ID: 11509682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.
    Coyne DW; Kapoian T; Suki W; Singh AK; Moran JE; Dahl NV; Rizkala AR;
    J Am Soc Nephrol; 2007 Mar; 18(3):975-84. PubMed ID: 17267740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency.
    Sultana T; DeVita MV; Michelis MF
    Int Urol Nephrol; 2016 Sep; 48(9):1519-24. PubMed ID: 27170339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of serum ascorbic acid to serum vitamin B12, serum ferritin, and kidney stones in US adults.
    Simon JA; Hudes ES
    Arch Intern Med; 1999 Mar; 159(6):619-24. PubMed ID: 10090119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial hematologic effects of daily oral ascorbic acid therapy in ESRD patients with anemia and abnormal iron homeostasis: a preliminary study.
    Sirover WD; Siddiqui AA; Benz RL
    Ren Fail; 2008; 30(9):884-9. PubMed ID: 18925528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Labile plasma iron levels in chronic hemodialysis patients treated by intravenous iron supplementation.
    Bnaya A; Shavit L; Malyszko JS; Malyszko J; Slotki I
    Ther Apher Dial; 2020 Aug; 24(4):416-422. PubMed ID: 31762187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevation of blood thioredoxin in hemodialysis patients with hepatitis C virus infection.
    Kato A; Odamaki M; Nakamura H; Yodoi J; Hishida A
    Kidney Int; 2003 Jun; 63(6):2262-8. PubMed ID: 12753316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients.
    Fishbane S; Lynn RI
    Clin Nephrol; 1995 Oct; 44(4):238-40. PubMed ID: 8575123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidant enzymes show adaptation to oxidative stress in athletes and increased stress in hemodialysis patients.
    Knap B; Prezelj M; Buturović-Ponikvar J; Ponikvar R; Bren AF
    Ther Apher Dial; 2009 Aug; 13(4):300-5. PubMed ID: 19695063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased oxidative stress, decreased total antioxidant capacity, and iron overload in untreated patients with chronic hepatitis C.
    Venturini D; Simão AN; Barbosa DS; Lavado EL; Narciso VE; Dichi I; Dichi JB
    Dig Dis Sci; 2010 Apr; 55(4):1120-7. PubMed ID: 19513844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity and specificity of transferrin saturation and serum ferritin as markers of iron status after intravenous iron dextran in hemodialysis patients.
    Low CL; Bailie GR; Eisele G
    Ren Fail; 1997 Nov; 19(6):781-8. PubMed ID: 9415935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intravenous ascorbic acid medication on serum levels of soluble transferrin receptor in hemodialysis patients.
    Tarng DC; Hung SC; Huang TP
    J Am Soc Nephrol; 2004 Sep; 15(9):2486-93. PubMed ID: 15339999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antioxidant treatment in dialysis patients- importance of ferritin.
    Ersoy A
    Nephrol Dial Transplant; 2006 Jul; 21(7):2035-6. PubMed ID: 16504978
    [No Abstract]   [Full Text] [Related]  

  • 38. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
    McCarthy JT; Regnier CE; Loebertmann CL; Bergstralh EJ
    Am J Nephrol; 2000; 20(6):455-62. PubMed ID: 11146312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous iron supplementation in children on hemodialysis.
    Leijn E; Monnens LA; Cornelissen EA
    J Nephrol; 2004; 17(3):423-6. PubMed ID: 15365964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of oxidative stress after repeated intravenous iron supplementation.
    Mimić-Oka J; Savić-Radojević A; Pljesa-Ercegovac M; Opacić M; Simić T; Dimković N; Simić DV
    Ren Fail; 2005; 27(3):345-51. PubMed ID: 15957553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.